Enacts new Article 1B of Chapter 90 to permit health care providers to prescribe epinephrine auto-injectors to "authorized entities" and to permit pharmacists and health care providers to dispense pursuant to such prescriptions.  The term authorized entity is defined as an entity or organization (other than a school) where allergens capable of causing anaphylaxis may be present, such as camps, colleges, day care facilities, and amusement parks.

Allows authorized entities to maintain a supply of the auto-injectors. Allows employees or agents of the entities to administer an auto-injector to a person who appears to be experiencing anaphylaxis or to provide the auto-injector directly to that person or to a parent, guardian, or caregiver of that person.

Requires anaphylaxis training for designated employees or agents. Specifies required content for the training and authorized providers.

Provides immunity for authorized entities and their employees or agents, health care providers who prescribe the auto-injectors, pharmacists who fill the prescription, and any person who provides the anaphylaxis training. Also limits liability for authorized entities for acts occurring outside the state. 

Provides that the administration of an auto-injector does not constitute the practice of medicine.

Effective October 1, 2015.